Roivant Sciences Ltd. (NASDAQ: ROIV) reported Q4 EPS of $0.28, $0.57 better than the analyst estimate of ($0.29). Revenue for the quarter came in at $2.52 million versus the consensus estimate of $3.76 million.

For earnings history and earnings-related data on Roivant Sciences Ltd. (ROIV) click here.